Ever Source Wealth Advisors, LLC Intra Cellular Therapies, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 76 shares of ITCI stock, worth $9,595. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76
Previous 76
-0.0%
Holding current value
$9,595
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ITCI
# of Institutions
381Shares Held
84MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$1.22 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$798 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$667 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$486 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$385 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $11.9B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...